Association Between IL-17A +197 G/A Polymorphism and Cancer Risk: A Meta-Analysis-Reference-Cited by-同舟云学术

Association Between IL-17A +197 G/A Polymorphism and Cancer Risk: A Meta-Analysis

Published:2016-01 Issue:1 Volume:20 Page:24-30
ISSN:1945-0265
Container-title:Genetic Testing and Molecular Biomarkers
language:en
Short-container-title:Genetic Testing and Molecular Biomarkers

Author:

Lu Yunjie¹,Gu Jian¹,Lu Hao¹,Zhu Qing¹,Zhang Feng¹,Wang Xuehao¹,Lu Ling¹,Zhang Chuanyong¹

Affiliation:

1. Translational Medicine Research Center of Jiangning Hospital, Liver Transplantation Center of First Affiliated Hospital, Nanjing Medical University, Nanjing, China.

Publisher

Mary Ann Liebert Inc

Subject

Genetics(clinical),General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/gtmb.2015.0143

Reference33 articles.

1. Polymorphism in the interleukin-17A promoter contributes to gastric cancer

2. A review of global cancer burden: Trends, challenges, strategies, and a role for surgeons

3. Genetic polymorphisms of IL17A and pri-microRNA-938, targeting IL17A 3′-UTR, influence susceptibility to gastric cancer

4. The biological functions of IL-17 in different clinical expressions of Helicobacter pylori-infection

5. Inflammatory Mediators Alter Interleukin-17 Receptor, Interleukin-12 and -23 Expression in Human Osteoarthritic and Rheumatoid Arthritis Synovial Fibroblasts: Immunomodulation by Vasoactive Intestinal Peptide

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associations of IL-4, IL-4R, IL-17A, and IL-17F Polymorphisms with Colorectal Cancer Risk: A Meta-Analysis, Meta-Regression, and Trial Sequential Analysis;Journal of Interferon & Cytokine Research;2022-05-01

2. IL17A and IL17F Genetic Variations in Iranian Patients with Urothelial Bladder Cancer: A Case-Control Study;MIDDLE EAST J CANCER;2021

3. The IL-17A rs2275913 polymorphism is associated with colorectal cancer risk;Journal of International Medical Research;2020-12

4. Association between interleukin gene polymorphisms and multiple myeloma susceptibility;Molecular and Clinical Oncology;2020-01-16

5. Monoclonal Antibodies Targeting the IL-17/IL-17RA Axis: An Opportunity to Improve the Efficiency of Anti-VEGF Therapy in Fighting Metastatic Colorectal Cancer?;Clinical Colorectal Cancer;2018-03